AstraZeneca Pharma India Company Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.

The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.

AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

AstraZeneca Pharma India Limited

Country	India
Founded	1979
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	600
CEO	Praveen Akkinepally

Contact Details

Address: Manyata Embassy Business Park Bengaluru, 560045 India
Phone	91 80 6774 8000
Website	astrazeneca.in

Stock Details

Ticker Symbol	ASTRAZEN
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE203A01020
SIC Code	2834

Key Executives

Name	Position
Bhavana Agrawal	Whole-Time Director and Chief Financial Officer
Praveen Rao Akkinepally	MD and Director
Tanya Sanish	Company Secretary and Compliance Officer
Sandhya Amanna	Director of Legal
Smita Saha	Vice President of Human Resources
Ayush Kumar Agarwal	Business Unit Head of Biopharmaceutical Business Unit
Vinay Sharma	Business Unit Head - Rare Disease unit
Amarpreet Kaur Ahuja	Country Human Resources Director
Srikanth B. S.	Site Lead, India Operations